175 related articles for article (PubMed ID: 29797496)
21. Network measures for chemical library design.
Sukumar N; Krein MP; Prabhu G; Bhattacharya S; Sen S
Drug Dev Res; 2014 Sep; 75(6):402-11. PubMed ID: 25195584
[TBL] [Abstract][Full Text] [Related]
22. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
Abdolmaleki A; Ghasemi JB; Ghasemi F
Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
[TBL] [Abstract][Full Text] [Related]
23. Quantitative chemogenomics: machine-learning models of protein-ligand interaction.
Andersson CR; Gustafsson MG; Strömbergsson H
Curr Top Med Chem; 2011; 11(15):1978-93. PubMed ID: 21470169
[TBL] [Abstract][Full Text] [Related]
24. In-Silico Molecular Binding Prediction for Human Drug Targets Using Deep Neural Multi-Task Learning.
Lee K; Kim D
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703452
[TBL] [Abstract][Full Text] [Related]
25. Identifying Drug-Target Interactions with Decision Templates.
Yan XY; Zhang SW
Curr Protein Pept Sci; 2018; 19(5):498-506. PubMed ID: 27829344
[TBL] [Abstract][Full Text] [Related]
26. Tools for in silico target fishing.
Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Pujadas G; Garcia-Vallve S
Methods; 2015 Jan; 71():98-103. PubMed ID: 25277948
[TBL] [Abstract][Full Text] [Related]
27. PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach.
Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
SAR QSAR Environ Res; 2015; 26(10):783-93. PubMed ID: 26305108
[TBL] [Abstract][Full Text] [Related]
28. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
29. In Silico Drug-Target Profiling.
Trosset JY; Cavé C
Methods Mol Biol; 2019; 1953():89-103. PubMed ID: 30912017
[TBL] [Abstract][Full Text] [Related]
30. The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery.
Medina-Franco JL; Méndez-Lucio O; Martinez-Mayorga K
Adv Protein Chem Struct Biol; 2014; 96():1-37. PubMed ID: 25443953
[TBL] [Abstract][Full Text] [Related]
31. The importance of employing computational resources for the automation of drug discovery.
Rosales-Hernández MC; Correa-Basurto J
Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
[TBL] [Abstract][Full Text] [Related]
32. Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction.
Button AL; Hiss JA; Schneider P; Schneider G
Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27643811
[TBL] [Abstract][Full Text] [Related]
33. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.
Reker D; Rodrigues T; Schneider P; Schneider G
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4067-72. PubMed ID: 24591595
[TBL] [Abstract][Full Text] [Related]
34. Identifying multiple-target ligands via computational chemogenomics approaches.
Peng S; Lin X; Guo Z; Huang N
Curr Top Med Chem; 2012; 12(12):1363-75. PubMed ID: 22690683
[TBL] [Abstract][Full Text] [Related]
35. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
Chopra G; Samudrala R
Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
[TBL] [Abstract][Full Text] [Related]
36. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
[TBL] [Abstract][Full Text] [Related]
37. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
38. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.
Yamanishi Y; Kotera M; Kanehisa M; Goto S
Bioinformatics; 2010 Jun; 26(12):i246-54. PubMed ID: 20529913
[TBL] [Abstract][Full Text] [Related]
39. The Future of Computational Chemogenomics.
Jacoby E; Brown JB
Methods Mol Biol; 2018; 1825():425-450. PubMed ID: 30334216
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.
Cortés-Cabrera A; Morris GM; Finn PW; Morreale A; Gago F
Br J Pharmacol; 2013 Oct; 170(3):557-67. PubMed ID: 23826885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
